Argentina's Health Minister Carla Vizzotti Wednesday announced the country's entire population will receive the booster dose of the COVID-19 vaccine.
The fourth WHO global tobacco trends report release shows that there are 1.30 billion tobacco users globally compared to 1.32 billion in 2015. This number is expected to drop to 1.27 billion by 2025. Sixty countries are now on track to achieving the voluntary global target of a 30% reduction in tobacco use between 2010 and 2025: two years ago only 32 countries were on track.
Russia's flag carrier Aeroflot has announced a series of new routes as COVID-19 travel restrictions are being lifted internationally.
World Health Organization (WHO) partners Unitaid have announced an agreement with the Pfizer laboratories to manufacture generic oral drugs to be used against COVID-19.
The Chilean government Monday announced it will be reopening several land border crossings for nationals and foreigners alike as of Dec. 1, provided certain requirements are met.
The Government of Peru has decided people over 18 years of age who are not vaccinated against COVID-19 will be banned from closed public places as of Monday. The measures include shopping malls, restaurants and banks.
Chilean health authorities have reported the country is at its highest level of active cases in four months after the weekend. In this scenario, Health Minister Enrique Paris, has once again underlined the importance of preventive testing shead of the presidential, parliamentary and regional elections scheduled for Nov. 21.
Preliminary but seemingly conclusive results from Argentina's mid-term elections Sunday showed the ruling party of President Alberto Fernández and Vice President Cristina Fernández de Kirchner would be losing its majority in Congress after 38 years.
The Government of Austria has finally ruled in favor of a mandatory nationwide lockdown for all those unvaccinated against COVID-19, effective Nov. 15.
The pharmaceutical company Pfizer Friday filed an application before Brazil's National Health Surveillance Agency (Anvisa) for its COVID-19 vaccine named Comirnaty to be cleared for use on patients aged 5 to 11 years old.